Transduction pathways regulating the trophic effects of Saccharomyces boulardii in rat intestinal mucosa

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 2, 2010, Pages 175-185

  Buts, Jean Paul ^a   Keyser, Nadine De ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

D Glucose uptake; Disaccharidases; Polyamines; Probiotic; Saccharomyces boulardii; Transduction pathways

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DISACCHARIDE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROBIOTIC AGENT; PROTEIN CRKII; PROTEIN P21; PROTEIN SHC; SOS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIUM TRANSDUCTION; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; ENZYME PHOSPHORYLATION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTESTINE MUCOSA; MUCOSA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SACCHAROMYCES BOULARDII;

ANIMALS; DISACCHARIDASES; INTESTINAL MUCOSA; JEJUNUM; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-CRK; RATS; RATS, WISTAR; SACCHAROMYCES; SIGNAL TRANSDUCTION;

EID: 76749103306     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365520903453141     Document Type: Article

References (31)

1. Buts JP, Bernasconi P. Saccharomyces boulardii: basic science and clinical applications in gastroenterology. Gastroenterol Clin North Am 2005;34:515-532
2. Buts JP, Corthier G, Delmee M. Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants. J Pediatr Gastroenterol Nut 1993;16:419-445
3. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 2000;45:1462-1464
4. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic-associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006;101:812-822
5. Surawicz CM, Elmer G, Speelman P, McFarland LV, Chinn J, Van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989;96:981-988
6. Szajewska H, Skórka A, Dylag M. Meta-analysis: Saccharomyces boulardii for children with acute diarrhoea. Acta Paediatr 2008;94:44-47
7. Buts JP, Bernasconi P, Van Craynest MP, Maldague P, De Meyer R. Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatr Res 1986;20:192-196
8. Buts JP, De Keyser N, Stilmant C, Sokal E, Marandi S. Saccharomyces boulardii enhances N-terminal peptide hydrolysis in suckling rat small intestine by endoluminal release of a zinc-binding metalloprotease. Pediatr Res 2002;51:528-534
9. Buts JP, Stilmant C, Bernasconi P, Neirinck C, De Keyser N. Characterization of a,a-trehalase released in the intestinal lumen by the probiotic Saccharomyces boulardii. Scand J of Gastroenterol 2008;43:1489-1496
10. Buts JP, Bernasconi P, Vaerman JP, Dive C. Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci 1990;35:251-256
11. Buts JP, De Keyser N, Marandi S, Hermans D, Sokal EM, Chae YHE, et al. Saccharomyces boulardii upgrades cellular adaptation after proximal enterectomy in rats. Gut 1999;45:89-96.
12. Buts JP, De Keyser N, De Raedemaeker L. Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines. Pediatr Res 1994;36:522-527
13. Buts JP, De Keyser N. Effets of Saccharomyces boulardii on intestinal mucosa. Dig Dis Sci 2006;51:1485-1492
14. Buts JP, Dekeyser N, Stilmant C, Delem E, Smets FR, Sokal E. Saccharomyces boulardii producesin rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation. Pediatr Res 2006;60:24-29
15. Marandi S, De Keyser N, Stilmant C, Saliez A, Sokal EM, Guiot Y, et al. Ontogeny of MAP kinases in rat small intestine: premature stimulation by insulin of BBM hydrolases is regulated by ERKs but not by p-38 MAP kinase. Pediatr Res 2002;52:180-188
16. Messer M, Dahlqvist A. A one step ultramicromethod for the assayofintestinaldisaccharidases.AnalBiochem1966;14:376-392
17. Lowry OH, Rosenbrough WJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275
18. Inukai K, Funaki M, Ogihara T, Katagizi H, Kanda A, Anai H, et al. p85 alpha gene generates three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (PI 3-Kinase), p50alpha, p55alpha, and p85alpha, with different PI 3-kinase activity elevating responses to insulin. J Biol Chem 1997;272:7873-7882
19. Skolnik EY, Lee CH, Batzer A, Vincentini H, Zhou M, Daly R, et al. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and SHC: implications for insulin control of RAS signalling. EMBO J 1993;12:1929-1936
20. Van Der Geer P, Wiley S, Gish GD, Pawson T. The SHC adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions. Curr Biol 1996;6:1435-1444
21. Khokhlatchev AV, Canagarajah B, Wilsbacher J, Robinson M, Atkinson M, Goldsmith E, et al. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 1998;93:605-615
22. Marandi S, De Keyser N, Saliez A, Maernoudt AS, Sokal EM, Stimant C, et al. Insulin signal transduction in rat small intestine : role of MAP kinases in expression of mucosal hydrolases. Am J Physiol Gastrointest Liver Physiol 2001;43:G229-40.
23. Gille H, Kortenjan M, Thomae O, Moowaw C, Slaugther A, Cobb MH, et al. ERK phosphorylates Elk-1 mediated ternary complex formation and transactivation. EMBO J 1995;14:951-962
24. Taylor LK, Wang HC, Erickson RL. Newly identified stressresponsive protein kinases Krs-1 and Krs-2. Proc Natl Acad Sci USA 1996;93:10099-10104
25. Sung CK, Sánchez-Margalet V, Goldfine ID. Role of p85 subunit of phosphatidylinositol-3- kinase as an adaptor molecule linking the insulin receptor, p62, and GTPaseactivating protein. J Biol Chem 1994;269:12503-12507
26. Wong G, Müller O, Clark R, Conroy L, Moran MF, Polakis P, et al. Molecular cloning and nucleic acid binding properties of the GAP-associated tyrosine phosphoprotein p62. Cell 1992;69:551-558
27. When QP, Kozlowski M, Belham C. Regulation of the p70 S6 kinase by phosphorylation in vivo. J Biol Chem 1998;273:16621-16629
28. Beg AA, Baldwin AS. Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor. Oncogene 1994;9:1487-1492
29. Dahan S, Dalmasso G, Imbert V, Peyron JF, Rampal P, Czerucka D. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect Immun 2003;71:766-773
30. Poutholakis C. Review article : anti-inflammatory mechanisms of action of Saccharomyces boulardii. Aliment Pharmacol Ther 2009;30:826-833
31. Buts J-P, De Keyser N, Stilmant C, Delem E, Smets Fr et Sokal E. Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxinby dephosphorylation. Pediatr Res 2006;60:24-29